Benzothiazole

Details

Top
Internal ID 3e3b0519-de19-4b87-b162-544490091645
Taxonomy Organoheterocyclic compounds > Benzothiazoles
IUPAC Name 1,3-benzothiazole
SMILES (Canonical) C1=CC=C2C(=C1)N=CS2
SMILES (Isomeric) C1=CC=C2C(=C1)N=CS2
InChI InChI=1S/C7H5NS/c1-2-4-7-6(3-1)8-5-9-7/h1-5H
InChI Key IOJUPLGTWVMSFF-UHFFFAOYSA-N
Popularity 3,874 references in papers

Physical and Chemical Properties

Top
Molecular Formula C7H5NS
Molecular Weight 135.19 g/mol
Exact Mass 135.01427034 g/mol
Topological Polar Surface Area (TPSA) 41.10 Ų
XlogP 2.00
Atomic LogP (AlogP) 2.30
H-Bond Acceptor 2
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
95-16-9
BENZO[D]THIAZOLE
1,3-Benzothiazole
Benzosulfonazole
1-Thia-3-azaindene
Vangard BT
benzothiazol
USAF EK-4812
FEMA No. 3256
CHEBI:45993
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Benzothiazole

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9965 99.65%
Caco-2 + 0.9195 91.95%
Blood Brain Barrier + 0.9000 90.00%
Human oral bioavailability + 0.6857 68.57%
Subcellular localzation Lysosomes 0.5226 52.26%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9724 97.24%
OATP1B3 inhibitior + 0.9548 95.48%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.9124 91.24%
P-glycoprotein inhibitior - 0.9868 98.68%
P-glycoprotein substrate - 0.9912 99.12%
CYP3A4 substrate - 0.7186 71.86%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7441 74.41%
CYP3A4 inhibition - 0.9525 95.25%
CYP2C9 inhibition - 0.7541 75.41%
CYP2C19 inhibition + 0.9006 90.06%
CYP2D6 inhibition - 0.5991 59.91%
CYP1A2 inhibition + 0.9297 92.97%
CYP2C8 inhibition - 0.6864 68.64%
CYP inhibitory promiscuity + 0.6531 65.31%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8200 82.00%
Carcinogenicity (trinary) Non-required 0.5318 53.18%
Eye corrosion - 0.9379 93.79%
Eye irritation + 0.9952 99.52%
Skin irritation + 0.8063 80.63%
Skin corrosion - 0.8693 86.93%
Ames mutagenesis - 0.8300 83.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6857 68.57%
Micronuclear + 0.7007 70.07%
Hepatotoxicity + 0.8500 85.00%
skin sensitisation - 0.9436 94.36%
Respiratory toxicity - 0.8667 86.67%
Reproductive toxicity + 0.7111 71.11%
Mitochondrial toxicity - 0.9500 95.00%
Nephrotoxicity + 0.4729 47.29%
Acute Oral Toxicity (c) II 0.7611 76.11%
Estrogen receptor binding - 0.8286 82.86%
Androgen receptor binding - 0.8512 85.12%
Thyroid receptor binding - 0.8302 83.02%
Glucocorticoid receptor binding - 0.7372 73.72%
Aromatase binding - 0.6325 63.25%
PPAR gamma - 0.7479 74.79%
Honey bee toxicity - 0.9193 91.93%
Biodegradation - 0.9000 90.00%
Crustacea aquatic toxicity + 0.8100 81.00%
Fish aquatic toxicity + 0.7638 76.38%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL3577 P00352 Aldehyde dehydrogenase 1A1 25118.9 nM
Potency
via CMAUP
CHEMBL4159 Q99714 Endoplasmic reticulum-associated amyloid beta-peptide-binding protein 39810.7 nM
Potency
via CMAUP

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2035 P08912 Muscarinic acetylcholine receptor M5 92.95% 94.62%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 85.48% 91.11%
CHEMBL3902 P09211 Glutathione S-transferase Pi 83.37% 93.81%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 82.15% 95.50%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 81.33% 95.56%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 81.32% 94.08%
CHEMBL1293249 Q13887 Kruppel-like factor 5 81.02% 86.33%
CHEMBL1868 P17948 Vascular endothelial growth factor receptor 1 80.83% 96.47%
CHEMBL4145 Q9UKV0 Histone deacetylase 9 80.35% 85.49%

Cross-Links

Top
PubChem 7222
NPASS NPC287895
ChEMBL CHEMBL510309
LOTUS LTS0073984
wikiData Q419096